OLUKOTUN ADEOYE Y 4
4 · ARROWHEAD PHARMACEUTICALS, INC. · Filed Sep 14, 2021
Insider Transaction Report
Form 4
OLUKOTUN ADEOYE Y
Director
Transactions
- Sale
Common Stock
2021-09-13$63.76/sh−2,750$175,340→ 9,000 total - Sale
Common Stock
2021-09-13$63.76/sh−2,250$143,460→ 11,750 total
Footnotes (2)
- [F1]Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.
- [F2]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.